Ultragenyx Pharmaceutical (RARE) Q4 2020 Earnings

27OctConfirmed
Q1 2020
Q2 2020
Q3 2020
Q4 2020
-1.91
-1.14
-0.36
0.41

Details

Expected EPS
-1.16
Actual EPS
-1.13
Surprise EPS
0.03
Surprise Percent
+2.59%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.13 per share for Q4 2020.

0 Comments

Share your thoughts